Share class: Boule Diagnostics AB

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A13,88,33,1042,08,31,169 ( 53.64 %) 0 53.64 %

Major shareholders: Boule Diagnostics AB

NameStocks%Valuation
Svolder AB (Investment Management)
11.05 %
42,89,159 11.05 % 2 M kr
Nordea Investment Management AB
7.738 %
30,04,792 7.738 % 1 M kr
Protean Funds Scandinavia AB
6.185 %
24,01,988 6.185 % 920 778 kr
Aktia Bank Plc (Investment Management)
2.556 %
9,92,540 2.556 % 380 480 kr
ISEC Services AB
0.2822 %
1,09,580 0.2822 % 42 006 kr
FCG Fonder AB
0.0176 %
6,816 0.0176 % 2 613 kr
Skandia Fonder AB
0.014 %
5,431 0.014 % 2 082 kr
Mercer Global Investments Europe Ltd.
0.000901 %
350 0.000901 % 134 kr

Breakdown by shareholder type

Institutional27.84%
Unknown72.16%

Based on 1000 largest holdings

Geographical origin of shareholders

Sweden
25.28%
Finland
2.56%

Based on 1000 largest holdings

Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200